295 related articles for article (PubMed ID: 1905706)
1. Photodynamic cell killing effects and acute skin photosensitivity of aluminum-chloro-tetrasulfonated phthalocyanine and hematoporphyrin derivative.
Komatsu K
Jpn J Cancer Res; 1991 May; 82(5):599-606. PubMed ID: 1905706
[TBL] [Abstract][Full Text] [Related]
2. Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy.
Koshida K; Hisazumi H; Komatsu K; Hirata A; Uchibayashi T
Urol Res; 1993; 21(4):283-8. PubMed ID: 8212418
[TBL] [Abstract][Full Text] [Related]
3. [Phthalocyanine: a new photosensitizer in photodynamic therapy].
Hisazumi H; Hirata A; Uchibayashi T; Naito K; Miyoshi N
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1120-6. PubMed ID: 2350188
[TBL] [Abstract][Full Text] [Related]
4. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivative.
Lin CW; Amano T; Rutledge AR; Shulok JR; Prout GR
Cancer Res; 1988 Nov; 48(21):6115-20. PubMed ID: 2971434
[TBL] [Abstract][Full Text] [Related]
6. Activity of phthalocyanine photosensitizers against human glioblastoma in vitro.
Abernathey CD; Anderson RE; Kooistra KL; Laws ER
Neurosurgery; 1987 Oct; 21(4):468-73. PubMed ID: 3683779
[TBL] [Abstract][Full Text] [Related]
7. [Hematoporphyrin derivative-mediated photodynamic therapy for human nasopharyngeal carcinoma: a comparative study with CNE2 and C666-1 cell lines in vitro].
Yang XM; Luo RC; Ma HJ; Li LB; Ding XM; Yan X; Lü CW; Zhou XP
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):165-7. PubMed ID: 17355926
[TBL] [Abstract][Full Text] [Related]
8. Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine.
Marshall JF; Chan WS; Hart IR
Photochem Photobiol; 1989 May; 49(5):627-32. PubMed ID: 2755999
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the therapeutic effect of photoactivated hematoporphyrin derivative and aluminum disulfonated phthalocyanines on tumor bearing mice.
Canti G; Franco P; Marelli O; Cubeddu R; Taroni P; Ramponi R
Cancer Lett; 1990 Sep; 53(2-3):123-7. PubMed ID: 2208071
[TBL] [Abstract][Full Text] [Related]
10. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.
Anderson C; Hrabovsky S; McKinley Y; Tubesing K; Tang HP; Dunbar R; Mukhtar H; Elmets CA
Photochem Photobiol; 1997 May; 65(5):895-901. PubMed ID: 9155263
[TBL] [Abstract][Full Text] [Related]
11. Influence of hematoporphyrin derivative concentration, incubation time, temperature during incubation and laser dose fractionation on photosensitivity of normal hemopoietic progenitors or leukemic cells.
Foultier MT; Patrice T; Praloran V; Robillard N; Le Bodic L
Biochimie; 1989 Jul; 71(7):819-25. PubMed ID: 2528381
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
13. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
14. Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizer.
Chan WS; Svensen R; Phillips D; Hart IR
Br J Cancer; 1986 Feb; 53(2):255-63. PubMed ID: 2937437
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine.
Roberts WG; Klein MK; Loomis M; Weldy S; Berns MW
J Natl Cancer Inst; 1991 Jan; 83(1):18-23. PubMed ID: 1824598
[TBL] [Abstract][Full Text] [Related]
16. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
17. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo.
Bellnier DA; Prout GR; Lin CW
J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065
[TBL] [Abstract][Full Text] [Related]
18. Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma.
Maier A; Tomaselli F; Matzi V; Rehak P; Pinter H; Smolle-Jüttner FM
Ann Thorac Surg; 2001 Oct; 72(4):1136-40. PubMed ID: 11603425
[TBL] [Abstract][Full Text] [Related]
19. Intratumor injection as a more effective means of porphyrin administration for photodynamic therapy.
Amano T; Prout GR; Lin CW
J Urol; 1988 Feb; 139(2):392-5. PubMed ID: 3339759
[TBL] [Abstract][Full Text] [Related]
20. The study of killing effect and inducing apoptosis of 630-nm laser on lung adenocarcinoma A549 cells mediated by hematoporphyrin derivatives in vitro.
Lin C; Zhang Y; Zhu X; Cui S; Cao Y; Li R; Wang L
Lasers Med Sci; 2020 Feb; 35(1):71-78. PubMed ID: 31049741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
